Singapore Market Roundup, Singapore Market Roundup

Singapore Market Roundup

Thematic (Sector/Industry)

<ul>
<li>UOBKH lifts Valuetronics target price to $1.88 due to strong earnings outlook.</li>
<li>DBS's Tan keeps 'hold' on MINT amid wait for positive developments.</li>
<li>DBS keeps 'buy' on IHH Healthcare, raising target price to $3.39.</li>
</ul>


UOBKH lifts Valuetronics target price to $1.88 due to strong earnings outlook.
DBS's Tan keeps 'hold' on MINT amid wait for positive developments.
DBS keeps 'buy' on IHH Healthcare, raising target price to $3.39.


Singapore Market Roundup (29-May-2026): UOBKH raises Valuetronics target to $1.88 on strong

CEO, A. Stotz Investment Research

Dr. Andrew Stotz, CFA

Quantamental Investing to beat Benchmarks

A. Stotz Investment Research

We pick stocks. We construct portfolios. All our effort is focused on how to better pick stocks and construct portfolios. We serve fund management companies, family offices, and high net worth individuals.

<ul>
<li>We highlight 14 stocks in ASEAN that look interesting to us based on our FVMR Methodology</li>
<li>Portfolio changes: Five stocks remain, nine stocks added into portfolio</li>
<li>Since its inception, the portfolio has generated a before-fee total return of 317% versus MSCI ASEAN’s 64%</li>
</ul>


We highlight 14 stocks in ASEAN that look interesting to us based on our FVMR Methodology
Portfolio changes: Five stocks remain, nine stocks added into portfolio
Since its inception, the portfolio has generated a before-fee total return of 317% versus MSCI ASEAN’s 64%


<ul><li>DBS rates Wee Hur Holdings as 'buy' with a target price of 90 cents.</li><li>PhillipCapital resumes coverage on iX Biopharma, setting a target price of $1.</li><li>New private hospital to have minimal effect on current healthcare providers: DBS</li></ul>

DBS rates Wee Hur Holdings as 'buy' with a target price of 90 cents.PhillipCapital resumes coverage on iX Biopharma, setting a target price of $1.New private hospital to have minimal effect on current healthcare providers: DBS

Singapore Market Roundup (10-Apr-2026): DBS rates Wee Hur Holdings a 'buy' at 90 cents target.

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of Bursa stocks as of Oct 2nd. The aggregated short interest is USD1,438m.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Nestle (Malaysia), YTL Power International, IJM, Inari Amertron, Frontken.</li>
</ul>


We analyzed the changes in short interest of Bursa stocks as of Oct 2nd. The aggregated short interest is USD1,438m.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Nestle (Malaysia), YTL Power International, IJM, Inari Amertron, Frontken.


Bursa Short Interest Weekly (Oct 2nd): Nestle (Malaysia), YTL Power International, IJM, Frontken

<ul>
<li>We highlight 14 stocks in ASEAN that look interesting to us based on our FVMR methodology</li>
<li>Portfolio changes: Five stocks remain, nine new join the fray</li>
<li>Since its inception, it has generated a before-fee total return of 295% versus the MSCI ASEAN's  59%</li>
</ul>


We highlight 14 stocks in ASEAN that look interesting to us based on our FVMR methodology
Portfolio changes: Five stocks remain, nine new join the fray
Since its inception, it has generated a before-fee total return of 295% versus the MSCI ASEAN's  59%


Malaysia

IHH Healthcare Bhd provides healthcare services. The Company operates hospitals as well as medical centers, clinics and ancillary healthcare businesses across multiple countries, including Singapore, Malaysia, Turkey, The Peoples Republic of China, India, Hong Kong,  Macedonia, the Netherlands and Brunei.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

IHH Healthcare (IHH MK)

Singapore Market Roundup (29-May-2026): UOBKH raises Valuetronics target to $1.88 on strong

UOBKH raises Valuetronics target price to $1.88 due to strong earnings. DBS's Tan maintains 'hold' on MINT while awaiting positive developments.

Singapore Market Roundup

The Stocks to Own in ASEAN – Vol. 54

We highlight 14 stocks in ASEAN that look interesting to us based on our FVMR Methodology. Portfolio changes: Five stocks remain, nine stocks added...

A. Stotz Investment Research

Singapore Market Roundup (10-Apr-2026): DBS rates Wee Hur Holdings a 'buy' at 90 cents target.

DBS rates Wee Hur Holdings as 'buy' with a 90 cents target price. PhillipCapital resumes iX Biopharma coverage with a $1 target. New hospital won't...

Singapore Market Roundup

Bursa Short Interest Weekly (Oct 2nd): Nestle (Malaysia), YTL Power International, IJM, Frontken

We analyzed Bursa Malaysia short interest report for the past week and highlighted short interest changes in Nestle (Malaysia), YTL Power...

Ke Yan, CFA, FRM

The Stocks to Own in ASEAN – Vol. 53

We highlight 14 stocks in ASEAN that look interesting to us based on our FVMR methodology. Portfolio changes: Five stocks remain, nine stocks added.

A. Stotz Investment Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)